MEI Pharma
Quarterly Financials
| Values in thousands | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -169 | -61 | -368 | 247 |
EBITDA | -2,774 | -3,451 | -7,639 | -18,281 |
EBIT | -2,774 | -3,451 | -8,007 | -18,406 |
Net Income | -2,573 | -2,677 | -8,007 | -18,406 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,267 | -3,666 | -11,450 | -17,999 |
Cash | 20,472 | 23,739 | 6,952 | 3,705 |
Basic Shares | 6,663 | 6,663 | 6,663 | 6,663 |
Annual Financials
| Values in thousands | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|
Revenue | $65,297 | $48,816 | $40,697 |
Gross Profit | 64,914 | 47,001 | 40,697 |
EBITDA | 18,161 | -32,778 | -75,158 |
EBIT | 17,778 | -33,164 | -75,484 |
Net Income | 17,778 | -31,840 | -54,450 |
Net Change In Cash | 65,297 | 48,816 | 40,697 |
Free Cash Flow | -50,480 | -52,519 | -49,225 |
Cash | 3,705 | 16,906 | 15,740 |
Basic Shares | 6,663 | 6,660 | 6,260 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$0.38 |
2024-12-31 | -$0.40 |
2024-09-30 | -$1.20 |
2024-06-30 | -$2.76 |
